1.Experimental study of skin wound healing with epidermal stem cells from human hypertrophic scar in nude mice.
Shuping ZHOU ; Zhilong HUANG ; Jiguang MA ; Jingjing XU ; Jinglong CAI ; Xianlei ZONG ; Le DU
Chinese Journal of Plastic Surgery 2014;30(4):289-293
OBJECTIVETo investigate the effect of epidermal stem cells from human hypertrophic scar (HS-ESCs) on the skin wound healing in nude mice.
METHODS40 mice were randomly divided into two groups as experimental group (n = 20) and control group (n = 20). Wounds, 1 cm in diameters, were made on every mouse back. The wounds were treated with HS-ESCs and erythromycin ointment in experimental group, or only with erythromycin ointment in control group. The wound healing was observed during the following 14 days. The expression of collagen-I, collagen-III, epidermal growth factor (EGF), fibroblast growth factor (FGF2) , transforming growth factor (TGFbeta1, and TGFbeta2) were studied.
RESULTSThe wound healing time in the experimental group was (20.8 +/- 0.84) d, which was (25.6 +/- 0.89) d in the control group. HE staining revealed that the extent of vascularization in the experimental group was 11.60 +/- 0.55, while it was 8.04 +/- 0.33 in the control group. Immunochemistry analysis showed the expression of collagen-I, collagen-III, EGF, FGF2, TGFbeta1, and TGFbeta2 in the experimental group were significantly higher, compared with those in control group (P < 0.05).
CONCLUSIONHS-ESCs may promote wound healing through enhancement of the vascularization of the wound tissue and the expression of growth factors.
Animals ; Cicatrix, Hypertrophic ; pathology ; Epidermis ; cytology ; Female ; Humans ; Male ; Mice ; Mice, Nude ; Skin ; injuries ; Stem Cell Transplantation ; Stem Cells ; Wound Healing
2.Comparative study of biological characteristics of dermis mesenchymal stem cells from human hypertrophic scar skin and normal skin
Shuping ZHOU ; Jingjing XU ; Jinglong CAI ; Fuyou NIU ; Xianlei ZONG ; Le DU
Chinese Journal of Trauma 2014;30(5):388-393
Objective To lay a foundation for the clinical application and tissue engineering research of hypertrophic scar (HS)-derived DMSCs by comparing the biological characteristics of dermis mesenchymal stem cells (DMSCs) from human maturing-phase HS and normal skin.Methods Twenty maturing-phase HS specimens (scar group) and 20 normal skin specimens (control group) were selected to extract and sort DMSCs by two-step enzyme digestion.When cells in both groups were subcultured to 3rd generation,cell morphology and growth curve were observed; expressions of cell surface proteins CD29,CD49 and vimentin were tested by immunocytochemistry; cells with positively expressed surface proteins CD34,CD73,CD90,and CD105 were examined by flow cytometry; expressions of genes Oct4 and Nanog were tested by RT-PCR; cell potential to differentiate into lipoblasts,osteoblasts,and chondroblasts was assayed in inductive medium.Results DMSCs in both groups showed similar shape and growth curve.Cell markers CD29,CD49 and vimentin expressed positively.Of scar and control groups,expressions of CD34,CD73,CD90,and CD105 were (0.60±0.03)% vs (0.61 ±0.02)%,(98.90±0.80)%vs (99.00±0.70)%,(98.30±0.30)%vs (98.20±0.40)%,and (93.10± 0.40) % vs (93.00 ± 0.20) % respectively (P > 0.05) ; expressions of genes Oct4 and Nanog were 0.506±0.024 vs0.512±0.024 and 0.496 ±0.018 vs 0.494 ±0.023 (P>0.05).Both types of DMSCs were able to differentiate in vitro into lipoblasts,osteoblasts,and chondroblasts in invitro conductive medium.Conclusion DMSCs exist in maturing-phase HS and present biomechanical characteristics basically similar with those of normal human skin.
3.Prevention and treatment of lymphatic fistula after cervical lymph node dissection in thyroid carcinoma:9 cases report
Yantao FU ; Le ZHOU ; Daqi ZHANG ; Jingjing QIU ; Tianyu YU ; Hui SUN
Journal of Endocrine Surgery 2011;05(3):194-196
Objective To analyze prevention and management of lymphatic fistula after cervical lymph node dissection in thyroid carcinoma.Methods Clinical data of 9 cases of lymphatic fistula following neck dissection were analyzed retrospectively from Jan.2004 to Apr.2009.Results Of the 9 cases,4 cases had chylous fistula(3 were on the leftside and 1 was on the rightside),1 case had chylotborax,1 case had pleural effusion lymph,and 3 cases showed light yellow lymph.AII patients were cured finally by conservative methods.Conclusions Most lymphatic fistula can be cured by non-surgical treatment.Surgeons need to be familiar with the anatomic structure of neck lymphatic vessels.
4.Olanzapine May Inhibit Colonic Motility Associated with the 5-HT Receptor and Myosin Light Chain Kinase.
Jiarui ZHANG ; Ying QIAO ; Jingjing LE ; Daliang SUN ; Yangtai GUAN ; Zezhi LI
Psychiatry Investigation 2016;13(2):232-238
OBJECTIVE: To study whether the effects of olanzapine on gastrointestinal motility is related to the serotonin antagonism and myosin light chain kinase. METHODS: Male Sprague-Dawley rats were randomly divided into four groups. Olanzapine gavage was performed for each treatment group during the course of 30 continuous days, while the same volume of saline was given to the rats in the control group. Defecation of the rats was observed on days 7 and 30 after olanzapine gavage. The effects of olanzapine on contraction of colonic smooth muscles were observed in ex vivo experiments. A Western blot was used to evaluate expression levels of the serotonin transporter (SERT) and MLCK in colon segments of the rats. RESULTS: ResultsaaCompared to the control group, 5-160 µM of olanzapine could inhibit dose-dependently the contraction of colonic smooth muscle ex vivo experiments. The maximum smooth muscle contraction effects of 5-HT and acetylcholine significantly decreased after treatment with 40-160 µM of olanzapine. Constipation was found in the olanzapine-treated rats on day 7 and have sustained day 30 after gavage. Expression of MLCK in olanzapine-treated rats was significantly decreased, whereas the expression of SERT significantly increased on the day 7, then significantly decreased on the day 30 after olanzapine gavage. CONCLUSION: SERT and MLCK may involve in the inhibition of colonic contraction induced by olanzapine.
Acetylcholine
;
Animals
;
Antipsychotic Agents
;
Blotting, Western
;
Colon*
;
Constipation
;
Defecation
;
Gastrointestinal Motility
;
Humans
;
Male
;
Muscle, Smooth
;
Myosin Light Chains*
;
Myosin-Light-Chain Kinase*
;
Myosins*
;
Rats
;
Rats, Sprague-Dawley
;
Serotonin Plasma Membrane Transport Proteins
;
Serotonin*
5.Preparation and identification of recombinant PTD-maxadilan.
Le ZENG ; Rongjie YU ; Mingfang XU ; Jiansu CHEN ; Jingjing WANG ; Juan LI
Chinese Journal of Biotechnology 2009;25(11):1739-1745
In order to construct a novel fusion protein PTD-maxadilan (PTD-MAX) that can enter the blood-brain barrier (BBB) efficiently, a new gene encoding PTD-MAX was synthesized and cloned into the expression vector pKYB. The recombinant vector pKYB-PTD-MAX was transformed into Escherichia coli ER2566. The expression of fusion protein consisting of PTD-MAX, intein and chitin binding domain was induced by IPTG and the target PTD-MAX protein was purified using Intein Mediated Purification with an Affinity Chitin-binding Tag system. The molecular weight of PTD-MAX determined by the laser flight mass spectrometry was coherent with its theoretical value. The results of the experiment in vivo indicated that the recombinant PTD-MAX can permeate into BBS and inhibitory effects on the food intake were more significantly than maxadilan (P<0.05). The preparation of PTD-MAX lay the foundation for its further application.
Animals
;
Base Sequence
;
Blood-Brain Barrier
;
metabolism
;
Escherichia coli
;
genetics
;
metabolism
;
Genetic Vectors
;
genetics
;
Insect Proteins
;
biosynthesis
;
genetics
;
pharmacokinetics
;
Mice
;
Molecular Sequence Data
;
Protein Structure, Tertiary
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
pharmacokinetics
;
Vasodilator Agents
;
metabolism
;
pharmacokinetics
6.Association between frailty and lifestyle factors among middle-aged and elderly populations
Jingjing LIN ; Yushan DU ; Mingbin LIANG ; Xiangyu CHEN ; Qingfang HE ; Hui XU ; Jiasheng QIN ; Feng LU ; Lixin WANG ; Jieming ZHONG ; Le FANG
Journal of Preventive Medicine 2022;34(3):263-267
Objective:
To examine the correlation between frailty and lifestyle factors among middle-aged and elderly populations, so as to provide insights into the management of frailty among middle-aged and elderly populations.
Methods :
Middle-aged and elderly residents at ages of 45 ot 69 years were recruited using the convenient sampling method from seven townships in Changxing County of Zhejiang Province from 2019 to 2020. The demographic characteristics and lifestyle factors were collected using questionnaires, and the frailty was measured using the Chinese version of Tilburg Frailty Indicator ( TFI ). Factors affecting frailty were identified among middle-aged and elderly populations using the multivariable logistic regression model.
Results:
A total of 7 170 residents were surveyed, including 2 780 males ( 38.77% ) and 4 390 females ( 61.23% ), which had a median age of 56 (interquartile range, 10) years. The median frailty score was 2 (interquartile range, 3 ) among the study subjects, and the median frailty score was 2 ( interquartile range, 2 ) among residents at ages of 45 to 59 years, and 2 (interquartile range, 3) among residents at ages of 60 to 69 years. The overall detection of frailty was 16.07%, and the detection of frailty was 13.52% among subjects at ages of 45 to 59 years and 21.01% among subjects at ages of 60 to 69 years. Multivariable logistic regression analysis identified physical activity ( OR=0.826, 95%CI: 0.719-0.949 ) and sleep quality ( OR: 3.376-11.493, 95%CI: 2.907-15.808 ) as factors affecting frailty among middle-aged and elderly residents. Following age stratification, physical activity ( OR=0.817, 95%CI: 0.681-0.981 ) and sleep quality ( OR: 3.076-11.566, 95%CI: 2.518-18.216 ) as factors affecting frailty among subjects at ages of 45 to 59 years, while sleep quality ( OR: 3.777-11.827, 95%CI: 3.002-18.547 ) significantly correlated with frailty among residents at ages of 60 to 69 years.
Conclusion
Physical activity and sleep quality are associated with the risk of frailty among middle-aged and elderly populations.
7.miR-143 suppresses the proliferation and migration of SGC7901 gastric cancer cells
Xinyi WANG ; Haiyang ZHANG ; Shuang LI ; Tao NING ; Le ZHANG ; Jingjing DUAN ; Yanjun QU ; Yiran SI ; Yi WANG ; Guoguang YING ; Yi BA
Chinese Journal of Clinical Oncology 2016;43(16):702-706
Objective:To investigate the role and mechanism of miR-143 in the proliferation and migration of gastric cancer (GC) cells. Methods:Western blot was performed to detect the expression level of avian erythroblastosis oncogene B-3 (ERBB3) in GC tissues, paired non-cancerous tissues, and SGC7901 GC cells. RT-qPCR was conducted to determine the mRNA and miR-143 of ERBB3 quantita-tively. Bioinformatics tools were used to predict the target gene of miR-143. Luciferase reporter assay was carried out to confirm the predicted target gene. Transwell and EdU assays were applied to observe the migration and proliferation of SGC7901 GC cells transfect-ed with miR-143 mimics/inhibitor/NC mimics/inhibitor. Results:Compared with the expression levels of ERBB3 and miR-143 in the paired non-cancerous tissues, the expression level of ERBB3 was upregulated and the expression level of miR-143 was downregulated in GC tissues. In the prediction of the potential target gene, miR-143 could bind to a specific sequence of the 3′-untranslated regions (UTR) of the mRNA of ERBB3. This finding was supported by luciferase reporter assay results. In vitro, ERBB3 protein expression and cell migration and proliferation were suppressed significantly in the SGC7901 cells transfected with miR-143 mimics. By contrast, these processes were remarkably enhanced when the cells were transfected with miR-143 inhibitor. Conclusion:miR-143 can suppress the migration and proliferation of GC cells by downregulating the expression of ERBB3.
8.Non-coding RNA-mediated TGF-β1/Smads Signaling Pathway and Liver Fibrosis, and Intervention by Active Components of Chinese Medicinal: A Review
Yong CHEN ; Ruisheng WU ; Jingjing WANG ; Le QIN ; Guidong HUANG ; Zhipin ZHOU
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(7):252-261
Liver fibrosis is a wound healing response that occurs in the setting of chronic liver injury and is caused by imbalance in the synthesis and degradation of extracellular matrix (ECM). If left untreated, it can progress to liver cirrhosis and hepatocellular carcinoma. The activation of hepatic stellate cell (HSC) is now well established as a central driver of liver fibrosis. The activated HSC will transform into myofibroblasts that produce ECM protein. Transforming growth factor-β1 (TGF-β1) can induce the activation of hepatic stellate cell (HSC), and TGF-β1/Smads signaling pathway is one of the important pathways to promote liver fibrosis. Non-coding RNA (ncRNA) does not encode proteins during the transcription but plays an important regulatory role in the post-transcriptional process of genes. Accumulating evidence shows that the occurrence of liver fibrosis is closely related to the abnormal expression of ncRNA which participates in the activation of HSC by regulating TGF-β1 signal transduction and then affects the process of liver fibrosis. MiRNA-mediated TGF-β1/Smads signaling pathway can not only promote liver fibrosis but also play a role in anti-fibrosis. Long non-coding RNA (lncRNA) not only promotes the development of liver fibrosis by binding to target genes but also enhances TGF-β1 signal transduction by acting as competitive endogenous RNA. circular RNA (circRNA) acts as a ''sponge'' to regulate TGF-β1/Smads pathway, thereby inhibiting HSC activation and exerting the anti-liver fibrosis effect. Chinese medicinal plays an essential part in the prevention and treatment of liver fibrosis, and the active components can inhibit TGF-β1/Smads pathway by regulating the expression of miRNA, thus alleviating liver fibrosis. This article reviews the role and mechanism of miRNA-, lncRNA- and circRNA-mediated TGF-β1/Smads signaling pathway in liver fibrosis and summarizes the anti-liver fibrosis effect of active components of Chinese medicinals by regulating miRNA-mediated TGF-β1/Smads signaling pathway, which can serve as a reference for clinical treatment of liver fibrosis and the development of new drugs.
9.Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer.
Haiyang ZHANG ; Jingjing DUAN ; Yanjun QU ; Ting DENG ; Rui LIU ; Le ZHANG ; Ming BAI ; Jialu LI ; Tao NING ; Shaohua GE ; Xia WANG ; Zhenzhen WANG ; Qian FAN ; Hongli LI ; Guoguang YING ; Dingzhi HUANG ; Yi BA
Protein & Cell 2016;7(2):141-151
Gastric cancer is one of the most common malignancies worldwide; however, the molecular mechanism in tumorigenesis still needs exploration. BCL2L11 belongs to the BCL-2 family, and acts as a central regulator of the intrinsic apoptotic cascade and mediates cell apoptosis. Although miRNAs have been reported to be involved in each stage of cancer development, the role of miR-24 in GC has not been reported yet. In the present study, miR-24 was found to be up-regulated while the expression of BCL2L11 was inhibited in tumor tissues of GC. Studies from both in vitro and in vivo shown that miR-24 regulates BCL2L11 expression by directly binding with 3'UTR of mRNA, thus promoting cell growth, migration while inhibiting cell apoptosis. Therefore, miR-24 is a novel onco-miRNA that can be potential drug targets for future clinical use.
Animals
;
Apoptosis
;
genetics
;
Apoptosis Regulatory Proteins
;
deficiency
;
genetics
;
Base Sequence
;
Bcl-2-Like Protein 11
;
Cell Line, Tumor
;
Cell Movement
;
genetics
;
Cell Proliferation
;
genetics
;
Down-Regulation
;
genetics
;
Gene Silencing
;
Male
;
Membrane Proteins
;
deficiency
;
genetics
;
Mice
;
MicroRNAs
;
genetics
;
Proto-Oncogene Proteins
;
deficiency
;
genetics
;
Rats
;
Stomach Neoplasms
;
genetics
;
pathology